Drug shortage
Rocuronium Bromide Injection · Meitheal Pharmaceuticals, Inc.
FDA drug shortage · Current · updated Mar 5, 2025
Key facts
| Generic name | Rocuronium Bromide Injection |
|---|---|
| Proprietary name | Rocuronium Bromide |
| Company | Meitheal Pharmaceuticals, Inc. |
| Presentation | Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06) |
| Dosage form | Injection |
| Strength | 10 mg/1 mL |
| Status | Current |
| Therapeutic category | Anesthesia |
| Package NDCs | 71288-700-06 |
| First posted | Feb 15, 2023 |
| Last updated | Mar 5, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: